结核病依旧是21世纪严重危害人类健康的疾病,耐药结核病是21世纪全球结核病控制面临的重大课题之一。为此,对我院初、复治患者耐药情况作了研究,为初、复治患者制定化疗方案经验选药提供依据。我们的研究显示:与1990年全国结核病流行病学抽样调查结果(耐药率28.1%)相比仍然偏高,与发达国家耐药率5%的水平相比则更高,耐2种 Tuberculosis is still a disease that is seriously endangering human health in the 21st century. Drug-resistant tuberculosis is one of the major topics in the global control of tuberculosis in the 21st century. To this end, early in our hospital, patients with refractory disease were studied for initial and retreatment patients to develop chemotherapy programs to provide empirical basis for drug selection. Our research shows that it is still high compared with the result of the national epidemiological survey of tuberculosis in 1990 (28.1% of the drug-resistant rate), and higher than the 5% level of the drug-resistant rate of the developed countries